Please login to your online account to display your discounted pricing

anti-DLL3, Polyclonal, Novus Biologicals™

Manufacturer: novus biologicals canada  NBP224669

 View more versions of this product


For Research Use Only

Catalog No. NBP224669

  • / Each

Description & Specifications


Gene ID (Entrez) 10683
Conjugate Unlabeled
Quantity 0.1mg
Format Purified
Primary or Secondary Primary
Concentration 0.5mg/mL
Gene Accession No. Q9NYJ7
Formulation 100μg antibody in 200μL PBS containing 0.05% BSA
Test Specificity The amino acid sequence used as immunogen is 100% homologous in human and monkey, 83% homologous in cat, 81% homologous in bovine and 72% homologous in mouse and rat. IMG-6242A detects the expected approximately 23 kD band in mouse and rat skeletal muscle tissue lysate, but additional larger molecular weight bands may be seen.
Regulatory Status RUO
Cross Reactivity Human
Cross Reactivity Mouse
Cross Reactivity Primate
Immunogen A portion of amino acid 100 to 150 of human DLL3 was used as immunogen for the antibody.
Host Species Rabbit
Applications Immunohistochemistry (Paraffin)
Applications Western Blotting
Antigen DLL3
Monoclonal or Polyclonal Polyclonal